Cathelijne van Zelst

Cathelijne van Zelst is a Researcher in the Pulmonary Medicine department at Erasmus MC, focusing on respiratory diseases with particular expertise in asthma and COPD research. Her work bridges clinical practice and advanced data analysis, with strong emphasis on personalized medicine approaches and disease burden assessment.

Her research interests span multiple critical areas in respiratory medicine, with primary focus on asthma (100% research fingerprint match) and significant contributions to understanding severe asthma (34%), body mass effects (30%), and principal component analysis applications (26%). She investigates immunological aspects of respiratory diseases, particularly innate lymphoid cells in COPD, and evaluates novel treatments like dupilumab for severe asthma. Her work often employs advanced statistical methods to stratify patients and personalize treatment approaches.

Analysis of her recent publications reveals a clear trend toward integrating technology with respiratory care, including wearable devices for COPD monitoring and innovative methods for measuring disease burden across asthma and COPD. Her research consistently focuses on translating findings to real-world clinical practice, as evidenced by her Dutch cohort study on dupilumab and work on patient stratification for personalized medicine. The publications show strong collaboration within Erasmus MC, particularly with researchers in immunology and respiratory medicine.

Dr. van Zelst has contributed to the research community through dataset creation, including her 2023 dataset on COPD patient stratification which has been picked up by news outlets and shared across academic platforms. Her work demonstrates growing impact, with several publications receiving significant citations and readership, particularly her research on dupilumab efficacy which has 23 Scopus citations.